Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Karen-Sue B. Carlson MD, PhD

Karen-Sue B. Carlson MD, PhD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center
Member of the Neuroscience Research Center


I am willing to collaborate on research projects.
I am willing to mentor a junior faculty member.


Research Areas of Interest

  • Bone Marrow Cells
  • Hematologic Neoplasms
  • Laminin
  • Leukemia, Myeloid, Acute
  • Schwann Cells
  • Stem Cell Niche
  • Publications (36)

  • Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems? (Carlson KS, Cunningham A, Stahl M, Winer E, Michaelis LC) Acta Haematol 2024;147(2):122-132 PMID: 38071966 SCOPUS ID: 2-s2.0-85189119120 12/11/2023    
  • MiR-9-1 controls osteoblastic regulation of lymphopoiesis. (Zhang Y, Lin D, Zheng Y, Chen Y, Yu M, Cui D, Huang M, Su X, Sun Y, Chen Y, Qian Z, Carlson KS, Wen R, Wang D) Leukemia 2023 Nov;37(11):2261-2275 PMID: 37670087 PMCID: PMC10844005 SCOPUS ID: 2-s2.0-85169811460 09/06/2023       1 Citation
  • Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study. (Zhang T, Auer P, Dong J, Cutler C, Dezern AE, Gadalla SM, Deeg HJ, Nazha A, Carlson KS, Spellman S, Bolon YT, Saber W) J Hematol Oncol 2023 Apr 11;16(1):37 PMID: 37041565 PMCID: PMC10088148 SCOPUS ID: 2-s2.0-85152260295 04/12/2023       3 Citations
  • Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology. (Zorn KE, Cunningham AM, Meyer AE, Carlson KS, Rao S) Cancers (Basel) 2023 Feb 24;15(5) PMID: 36900239 PMCID: PMC10000481 SCOPUS ID: 2-s2.0-85149898211 03/12/2023       4 Citations
  • A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. (Kleman A, Singavi A, Pommert L, Mathison AJ, Hari P, Dhakal B, Mohan M, Janz S, Knight JM, Shah MV, Schinke C, Burns R, Steinhardt GF, Rao S, Carlson K) Blood Adv 2023 Sep 26;7(18):5549-5553 PMID: 36724511 PMCID: PMC10514068 SCOPUS ID: 2-s2.0-85164933174 02/02/2023       1 Citation
  • Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia. (Abedin SM, Badar T, Gauger K, Michaelis LC, Runaas L, Carlson KS, Murthy GG, Atallah E) Leuk Res 2022 Dec;123:106984 PMID: 36401944 SCOPUS ID: 2-s2.0-85141943453 11/20/2022       2 Citations
  • The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut. (Ramadan R, Wouters VM, van Neerven SM, de Groot NE, Garcia TM, Muncan V, Franklin OD, Battle M, Carlson KS, Leach J, Sansom OJ, Boulard O, Chamaillard M, Vermeulen L, Medema JP, Huels DJ) Biol Open 2022 Dec 15;11(12) PMID: 36350252 PMCID: PMC9713296 SCOPUS ID: 2-s2.0-85142918558 11/10/2022       2 Citations
  • Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol. (Johnson AK, Lorimer EL, Szabo A, Wu R, Shah NN, D'Souza A, Chhabra S, Hamadani M, Dhakal B, Hari P, Rao S, Carlson K, Williams CL, Knight JM) Yale J Biol Med 2022 Mar;95(1):45-56 PMID: 35370486 PMCID: PMC8961707 SCOPUS ID: 2-s2.0-85127524780 04/05/2022       2 Citations
  • Revisiting biochemistry: severe euglycemic ketoacidosis in the setting of IDH-inhibitor therapy for AML. (Khan M, Roddy JT, Hernandez JR, Bursch K, Bal N, Carlson KS, Bergl PA) Br J Haematol 2021 Sep;194(6):1083-1085 PMID: 34101165 SCOPUS ID: 2-s2.0-85107327472 06/09/2021    
  • Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes. (Wang W, Auer P, Zhang T, Spellman S, Carlson KS, Nazha A, Bolon YT, Saber W) Transplant Cell Ther 2021 Aug;27(8):659.e1-659.e6 PMID: 33992829 PMCID: PMC8421055 SCOPUS ID: 2-s2.0-85108524869 05/17/2021       6 Citations
  • Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. (Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS) Leuk Lymphoma 2021 Jan;62(1):158-166 PMID: 32951486 SCOPUS ID: 2-s2.0-85091139710 09/22/2020       10 Citations
  • Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant. (Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman SR, Verneris MR, Hsu K, Fleischhauer K, Lee SJ, Bolon YT, Carlson KS, Nazha A, Saber W) Leuk Lymphoma 2021 Jan;62(1):229-233 PMID: 32924688 PMCID: PMC7939047 SCOPUS ID: 2-s2.0-85090933926 09/15/2020       1 Citation
  • Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature. (Yang C, Siebert JR, Burns R, Zheng Y, Mei A, Bonacci B, Wang D, Urrutia RA, Riese MJ, Rao S, Carlson KS, Thakar MS, Malarkannan S) Elife 2020 May 14;9 PMID: 32406817 PMCID: PMC7255804 SCOPUS ID: 2-s2.0-85085630468 05/15/2020       17 Citations
  • Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database. (Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E) J Natl Compr Canc Netw 2020 Feb;18(2):169-175 PMID: 32023530 SCOPUS ID: 2-s2.0-85079065513 02/06/2020       20 Citations
  • The Adult Murine Intestine is Dependent on Constitutive Laminin-γ1 Synthesis. (Fields B, DeLaForest A, Zogg M, May J, Hagen C, Komnick K, Wieser J, Lundberg A, Weiler H, Battle MA, Carlson KS) Sci Rep 2019 Dec 17;9(1):19303 PMID: 31848396 PMCID: PMC6917708 SCOPUS ID: 2-s2.0-85076615345 12/19/2019       6 Citations
  • Role of thrombomodulin expression on hematopoietic stem cells. (Basu S, Liang HPH, Hernandez I, Zogg M, Fields B, May J, Ogoti Y, Wyseure T, Mosnier LO, Burns RT, Carlson K, Weiler H) J Thromb Haemost 2020 Jan;18(1):123-135 PMID: 31628891 PMCID: PMC6940513 SCOPUS ID: 2-s2.0-85074837812 10/20/2019       3 Citations
  • Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. (Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S) Nat Commun 2019 Sep 02;10(1):3931 PMID: 31477722 PMCID: PMC6718415 SCOPUS ID: 2-s2.0-85071610251 09/04/2019       150 Citations
  • Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia. (Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N) Blood Adv 2019 May 14;3(9):1499-1511 PMID: 31076406 PMCID: PMC6517669 SCOPUS ID: 2-s2.0-85068626845 05/12/2019       19 Citations
  • Stem cell damage after chemotherapy- can we do better? (Tang J, Zhu N, Rao S, Carlson KS) Best Pract Res Clin Haematol 2019 Mar;32(1):31-39 PMID: 30927973 SCOPUS ID: 2-s2.0-85061244660 04/01/2019       4 Citations
  • Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy (Schneidewend R · Hosking P · Brazauskas R · Peterson J · Beaudin C · Michaelis L · Atallah E · Hari P · Carlson K) Acta Haematologica Acta Haematol 2018;139:171–175 03/29/2018    
  • Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation. (van Mens TE, Liang HH, Basu S, Hernandez I, Zogg M, May J, Zhan M, Yang Q, Foeckler J, Kalloway S, Sood R, Karlson CS, Weiler H) Blood Adv 2017 Jun 27;1(15):1148-1158 PMID: 28920104 PMCID: PMC5600150 SCOPUS ID: 2-s2.0-85050503897 09/19/2017       13 Citations
  • Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis. (Levin A, Kleman A, Rein L, Tarima S, Michaelis LC, Carlson KS, Hamadani M, Fenske TS, Hari P, Atallah E, Dhakal B) Am J Hematol 2017 Sep;92(9):E563-E565 PMID: 28631379 SCOPUS ID: 2-s2.0-85021972988 06/21/2017       4 Citations
  • Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. (Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M) Biol Blood Marrow Transplant 2017 Aug;23(8):1295-1302 PMID: 28412518 SCOPUS ID: 2-s2.0-85019639994 04/17/2017       8 Citations
  • Neuroserpin Differentiates Between Forms of Tissue Type Plasminogen Activator via pH Dependent Deacylation. (Carlson KS, Nguyen L, Schwartz K, Lawrence DA, Schwartz BS) Front Cell Neurosci 2016;10:154 PMID: 27378851 PMCID: PMC4908126 SCOPUS ID: 2-s2.0-84975166530 07/06/2016       4 Citations
  • Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms. (Hanif A, Hari PN, Atallah E, Carlson KS, Pasquini MC, Michaelis LC) Bone Marrow Transplant 2016 Apr;51(4):617-8 PMID: 26726940 SCOPUS ID: 2-s2.0-84953295752 01/05/2016       17 Citations
  • Acute Leukemia (Karen Carlson; Jesse B. Hall, Gregory A. Schmidt, John P. Kress Editors.) Principles of Critical Care, Fourth Edition 09/02/2015    
  • Should all adults with acute lymphocytic leukemia receive allogeneic stem cell transplantation in first remission? (Atallah Ehab, Carlson Karen Sue, Schiffer Charles) International Journal of Hematologic Oncology Atallah E, Carlson Karen Sue, Schiffer Charles. Should all adults with acute lymphocytic leukemia receive allogeneic stem cell transplantation in first remission? International Journal of Hematologic Oncology. 2014; 3(5):325-334. 02/17/2015    
  • Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients. (Ebenezer GJ, Carlson K, Donovan D, Cobham M, Chuang E, Moore A, Cigler T, Ward M, Lane ME, Ramnarain A, Vahdat LT, Polydefkis M) Ann Clin Transl Neurol 2014 Sep;1(9):639-49 PMID: 25493278 PMCID: PMC4241791 SCOPUS ID: 2-s2.0-84941801263 12/11/2014       27 Citations
  • Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions. (Chapin J, Carlson K, Christos PJ, DeSancho MT) Clin Appl Thromb Hemost 2015 Oct;21(7):672-7 PMID: 24335246 SCOPUS ID: 2-s2.0-84940846964 12/18/2013       14 Citations
  • Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia? (Carlson KS, Guzman ML) Curr Hematol Malig Rep 2013 Jun;8(2):109-15 PMID: 23563936 PMCID: PMC3661756 SCOPUS ID: 2-s2.0-84878768773 04/09/2013       9 Citations
  • Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia. (Ritchie EK, Feldman EJ, Christos PJ, Rohan SD, Lagassa CB, Ippoliti C, Scandura JM, Carlson K, Roboz GJ) Leuk Lymphoma 2013 Sep;54(9):2003-7 PMID: 23270581 PMCID: PMC3888021 SCOPUS ID: 2-s2.0-84879783893 12/29/2012       135 Citations
  • Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach. (Carlson K, Ocean AJ) Clin Breast Cancer 2011 Apr;11(2):73-81 PMID: 21569993 SCOPUS ID: 2-s2.0-80051720415 05/17/2011       124 Citations
  • Mesenchymal stem cells facilitate axon sorting, myelination, and functional recovery in paralyzed mice deficient in Schwann cell-derived laminin. (Carlson KB, Singh P, Feaster MM, Ramnarain A, Pavlides C, Chen ZL, Yu WM, Feltri ML, Strickland S) Glia 2011 Feb;59(2):267-77 PMID: 21125647 PMCID: PMC3118468 SCOPUS ID: 2-s2.0-78650252853 12/03/2010       47 Citations
  • A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement. (Mallik A, Carlson KB, DeSancho MT) Blood Coagul Fibrinolysis 2011 Jan;22(1):73-5 PMID: 21076280 SCOPUS ID: 2-s2.0-78650797980 11/16/2010       23 Citations
  • Hematological issues in critically ill patients with cancer. (Carlson KS, DeSancho MT) Crit Care Clin 2010 Jan;26(1):107-32 PMID: 19944278 SCOPUS ID: 2-s2.0-70449781150 12/01/2009       16 Citations
  • Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro. (Barker-Carlson K, Lawrence DA, Schwartz BS) J Biol Chem 2002 Dec 06;277(49):46852-7 PMID: 12228252 SCOPUS ID: 2-s2.0-0345829928 09/14/2002       55 Citations
  • Last update: 04/04/2024